The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is set to grow from $3.7 billion in 2016 to around $16.1 billion by 2026, according to research and consulting firm GlobalData. This represents an impressive compound annual growth rate of 15.7 percent.
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently started ...
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its technology in Europe.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 18, 2017 โ Corindus Vascular Robotics Inc. announced first patient enrollment in the PRECISION GRX Registry, a ...
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating the efficacy of Philips Spectranetics' Stellarex .035-inch drug-coated balloon (DCB) for peripheral arterial disease (PAD) in comparison to uncoated balloon angioplasty. Marianne Brodmann, M.D., of the Medical University of Graz in Austria, presented the data as a late-breaking trial at the Vascular Interventional Advances (VIVA 17) Annual Conference, Sept. 11-14 in Las Vegas.
September 18, 2017 โ Claret Medical announced publication of a new study in the Journal of the American College of ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its QMAPP hemodynamic monitoring system.
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Supria True64 computed tomography (CT) system.
September 15, 2017 โ Philips highlighted its newest solution for nuclear cardiology, CardioMD IV, at the American ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 14, 2017 โ Scientists at the National Institutes of Health have expanded the understanding of how chronic ...
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently in the European Journal of Preventive Cardiology.
September 14, 2017 โ Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease which can result in the loss of a limb. To help minimize amputations among their patient population, Capel Surgical Clinic & Vascular Center in Greenwood, Miss., uses advanced X-ray technology to restore blood flow in occluded arteries. Capel Surgical Clinic also uses the Ultimax-i FPD multipurpose system from Toshiba Medical, a Canon Group company, for interventional procedures, diagnostic angiograms and aortagrams.
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from Sept. 11 โ 14, 2017, applying advanced technologies and deep clinical insights to address peripheral vascular needs. With the addition of its recent acquisition, Spectranetics, Philips will for the first time highlight its expanded portfolio of interventional X-ray systems, advanced catheters for measurement and therapy, clinical informatics and services, including its Philips Azurion image-guided therapy platform, intravascular ultrasound (IVUS), Phoenix atherectomy system and Spectranetics' Stellarex drug-coated balloon.